Decibel Therapeutics, Inc.
CIK 0001656536
Revenue (TTM)
—
Q2 Aug 2023
Net Income (TTM)
−$64.5M
−21.6% YoY
Q2 Aug 2023
EPS Diluted (TTM)
−$2.58
−1.2% YoY
Q2 Aug 2023
Gross Margin
—
Q2 Aug 2023
Operating Margin
—
Q2 Aug 2023
Net Margin
—
Q2 Aug 2023
Free Cash Flow (TTM)
−$67.76M
Q2 Aug 2023
Cash
$39.8M
Q2 Aug 2023
Total Debt
—
Q2 Aug 2023
Shares Outstanding
25.13M sh
Q2 Aug 2023
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.